SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-042108
Filing Date
2024-04-02
Accepted
2024-04-02 06:00:51
Documents
8
Period of Report
2024-05-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm242879-2_pre14a.htm DEF 14A 820668
2 GRAPHIC bc_paidvsnetloss-4c.jpg GRAPHIC 41808
3 GRAPHIC bc_paidvstsr-4c.jpg GRAPHIC 44435
4 GRAPHIC lg_checkpointthera-4c.jpg GRAPHIC 70494
5 GRAPHIC px_24checkpointannual01-bw.jpg GRAPHIC 271915
6 GRAPHIC px_24checkpointannual02-bw.jpg GRAPHIC 297103
7 GRAPHIC sg_garrettgray-bw.jpg GRAPHIC 4613
8 GRAPHIC sg_jamesfoliviero-bw.jpg GRAPHIC 4669
  Complete submission text file 0001104659-24-042108.txt   1762514
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38128 | Film No.: 24812086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)